BioClinica, Inc. Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Newtown PA United States (1998)

Organization Overview

First Clinical Trial
2014
NCT02119091
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

BioClinica, Inc. | Bioclinica Research